This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Ultiva (Remifentanil) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (90)
Death (5)
Life Threatening Events (21)
Reports by Reaction Type
Drug Rash With Eosinophilia and Systemic Symptoms (21),
Premature Baby (11),
Drug Withdrawal Syndrome Neonatal (8),
Transient Tachypnoea of THE Newborn (8),
Vomiting (8),
Hyperreflexia (8),
Irritability (8),
Feeding Disorder (8),
Anaphylactic Shock (7),
Off Label Use (7),
Maternal Exposure During Pregnancy (7),
Premature Labour (7)
Below are a few examples of reports where side effects / adverse reactions may be related to Ultiva (Remifentanil). For a complete list or a specific selection of reports, please use the links above.
Possible Ultiva side effects in
Reported by a individual with unspecified qualification from France on 2012-08-23
Patient:
Reactions: Cardio-Respiratory Arrest, Anaphylactic Shock, Circulatory Collapse
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Diprivan
Dosage: 200 mg, once
Indication: General Anaesthesia
Start date: 2012-03-20
End date: 2012-03-20
Rocuronium Bromide
Dosage: 40 mg, once
Indication: General Anaesthesia
Start date: 2012-03-20
End date: 2012-03-20
Ultiva
Dosage: 50 ?g, once
Indication: General Anaesthesia
Start date: 2012-03-20
End date: 2012-03-20
Possible Ultiva side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-23
Patient: 67 year old female, weighing 47.0 kg (103.4 pounds)
Reactions: Hyperaesthesia, Posterior Reversible Encephalopathy Syndrome, Hypertension
Drug(s) suspected as cause:
Ketamine HCL
Dosage: 40mg administered intraoperatively
Ketamine HCL
Dosage: 40mg administered intraoperatively
Ketamine HCL
Indication: Induction of Anaesthesia
Ketamine HCL
Indication: Prophylaxis
Ultiva
Dosage: continuous infusion 0.15 microg/kg/hour
Indication: Maintenance of Anaesthesia
Other drugs received by patient: Heparin; Sevoflurane; Sugammadex; Propofol; Rocuronium Bromide; Fentanyl; Fentanyl
Possible Ultiva side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-23
Patient: 67 year old female, weighing 47.0 kg (103.4 pounds)
Reactions: Hyperaesthesia, Posterior Reversible Encephalopathy Syndrome, Hypertension
Drug(s) suspected as cause:
Ketamine HCL
Dosage: 40mg administered intraoperatively
Ketamine HCL
Indication: Prophylaxis
Ketamine HCL
Dosage: 40mg administered intraoperatively
Ketamine HCL
Indication: Induction of Anaesthesia
Ultiva
Dosage: continuous infusion 0.15 microg/kg/hour
Indication: Maintenance of Anaesthesia
Other drugs received by patient: Fentanyl; Rocuronium Bromide; Fentanyl; Heparin; Sevoflurane; Propofol; Sugammadex
Possible Ultiva side effects in 37 year old female
Reported by a physician from Japan on 2012-08-21
Patient: 37 year old female
Reactions: Acidosis, Respiratory Depression, Delayed Recovery From Anaesthesia, Convulsion, Respiration Abnormal
Drug(s) suspected as cause:
Buprenorphine HCL
Dosage: unit dose unknown
Indication: Analgesic Therapy
Start date: 2012-06-28
End date: 2012-06-28
Diprivan
Dosage: unit dose unknown
Indication: Sedation
Start date: 2012-06-28
End date: 2012-06-28
Ultiva
Dosage: unit dose unknown
Indication: Analgesic Therapy
Start date: 2012-06-28
End date: 2012-06-28
Other drugs received by patient: Zonisamide; Phenytoin
Possible Ultiva side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-20
Patient: 67 year old female, weighing 47.0 kg (103.4 pounds)
Reactions: Posterior Reversible Encephalopathy Syndrome
Drug(s) suspected as cause:
Fentanyl
Dosage: intermittent doses for maintenance
Fentanyl
Indication: General Anaesthesia
Ketamine HCL
Dosage: induction
Indication: General Anaesthesia
Ketamine HCL
Dosage: during anesthesia
Propofol
Propofol
Propofol
Propofol
Propofol
Indication: General Anaesthesia
Sevoflurane
Dosage: 1.3%
Indication: General Anaesthesia
Ultiva
Dosage: continuous infusion of 0.15 mcg/kg/h
Indication: General Anaesthesia
Other drugs received by patient: Warfarin Sodium; Sugammadex; Benidipine; Cipralan; Heparin; Rocuronium Bromide; Warfarin Sodium
Possible Ultiva side effects in 37 year old female
Reported by a physician from Japan on 2012-08-17
Patient: 37 year old female
Reactions: Respiratory Depression, Acidosis, Delayed Recovery From Anaesthesia, Convulsion, Respiration Abnormal
Drug(s) suspected as cause:
Buprenorphine HCL
Dosage: unit dose unknown
Indication: Analgesic Therapy
Start date: 2012-06-28
End date: 2012-06-28
Diprivan
Dosage: unit dose unknown
Indication: Sedation
Start date: 2012-06-28
End date: 2012-06-28
Ultiva
Dosage: unit dose unknown
Indication: Analgesic Therapy
Start date: 2012-06-28
End date: 2012-06-28
Other drugs received by patient: Phenytoin; Zonisamide
Possible Ultiva side effects in 85 year old male
Reported by a physician from Canada on 2012-08-16
Patient: 85 year old male
Reactions: Drug Ineffective
Drug(s) suspected as cause:
Ultiva
Possible Ultiva side effects in male
Reported by a physician from Japan on 2012-08-08
Patient: male, weighing 2.5 kg (5.4 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Transient Tachypnoea of THE Newborn, Vomiting, Premature Baby, Hyperreflexia, Drug Withdrawal Syndrome Neonatal, Irritability, Gamma-Glutamyltransferase Increased, Feeding Disorder, Analgesic Drug Level Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fentanyl Citrate
Indication: Foetal Exposure During Pregnancy
Start date: 2011-10-25
End date: 2011-10-25
Fentanyl-100
Indication: Foetal Exposure During Pregnancy
Start date: 2005-01-01
End date: 2011-10-27
Metoclopramide
Indication: Foetal Exposure During Pregnancy
Morphine HCL Elixir
Indication: Foetal Exposure During Pregnancy
Phenobarbital TAB
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-27
End date: 2011-10-27
Phenobarbital TAB
Start date: 2011-10-27
End date: 2011-10-31
Ultiva
Indication: Foetal Exposure During Pregnancy
Start date: 2011-10-25
End date: 2011-10-25
Possible Ultiva side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-07
Patient: female
Reactions: Off Label Use, Maternal Exposure During Pregnancy, Premature Labour, Drug Prescribing Error
Drug(s) suspected as cause:
Fentanyl Citrate
Indication: General Anaesthesia
Start date: 2011-10-25
End date: 2011-10-25
Fentanyl-100
Indication: Procedural Pain
Start date: 2005-01-01
End date: 2011-10-27
Fentanyl-100
Indication: Pain
Start date: 2005-01-01
End date: 2011-10-27
Metoclopramide
Administration route: Oral
Indication: Uterine Contractions During Pregnancy
Morphine HCL Elixir
Indication: Uterine Contractions During Pregnancy
Start date: 2005-01-01
Ultiva
Indication: General Anaesthesia
Start date: 2011-10-25
End date: 2011-10-25
Possible Ultiva side effects in 37 year old female
Reported by a physician from Japan on 2012-08-03
Patient: 37 year old female
Reactions: Respiratory Depression, Acidosis, Delayed Recovery From Anaesthesia, Convulsion, Respiration Abnormal
Drug(s) suspected as cause:
Buprenorphine HCL
Dosage: unit dose unknown
Indication: Analgesic Therapy
Start date: 2012-06-28
End date: 2012-06-28
Diprivan
Dosage: unit dose unknown
Indication: Sedation
Start date: 2012-06-28
End date: 2012-06-28
Ultiva
Dosage: unit dose unknown
Indication: Analgesic Therapy
Start date: 2012-06-28
End date: 2012-06-28
Possible Ultiva side effects in
Reported by a consumer/non-health professional from Japan on 2012-07-30
Patient:
Reactions: Pharyngeal Oedema, Cardio-Respiratory Arrest
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Diprivan
Dosage: 100 mg, once
Indication: Anaesthesia Procedure
Start date: 2011-11-24
End date: 2011-11-24
Rocuronium Bromide
Indication: Neuromuscular Blocking Therapy
Start date: 2011-11-24
End date: 2011-11-24
Rocuronium Bromide
Dosage: 50 mg, once
Start date: 2011-11-24
End date: 2011-11-24
Ultiva
Dosage: perpetuation administering during 0.5mcg/kg/minute
Indication: Analgesic Therapy
Start date: 2011-11-24
End date: 2011-11-24
Ultiva
Possible Ultiva side effects in
Reported by a physician from Japan on 2012-07-30
Patient:
Reactions: Piloerection, Anaphylactic Reaction, Blood Pressure Decreased
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Propofol
Indication: Light Anaesthesia
Start date: 2012-07-12
End date: 2012-07-12
Rocuronium Bromide
Start date: 2012-07-12
End date: 2012-07-12
Ultiva
Dosage: unk unk, once
Indication: Analgesic Therapy
Start date: 2012-07-12
End date: 2012-07-12
Possible Ultiva side effects in male
Reported by a physician from Japan on 2012-07-30
Patient: male, weighing 2.5 kg (5.4 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Vomiting, Transient Tachypnoea of THE Newborn, Premature Baby, Hyperreflexia, Drug Withdrawal Syndrome Neonatal, Irritability, Gamma-Glutamyltransferase Increased, Feeding Disorder, Analgesic Drug Level Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fentanyl Citrate
Indication: Foetal Exposure During Pregnancy
Start date: 2011-10-25
End date: 2011-10-25
Fentanyl-100
Indication: Foetal Exposure During Pregnancy
Start date: 2005-01-01
End date: 2011-10-27
Metoclopramide
Indication: Foetal Exposure During Pregnancy
Morphine Hydrochloride
Indication: Foetal Exposure During Pregnancy
Phenobarbital TAB
Start date: 2011-10-27
End date: 2011-10-31
Phenobarbital TAB
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-27
End date: 2011-10-27
Ultiva
Indication: Foetal Exposure During Pregnancy
Start date: 2011-10-25
End date: 2011-10-25
Possible Ultiva side effects in female
Reported by a physician from Japan on 2012-07-30
Patient: female
Reactions: Off Label Use, Maternal Exposure During Pregnancy, Drug Prescribing Error, Premature Labour
Drug(s) suspected as cause:
Fentanyl Citrate
Indication: General Anaesthesia
Start date: 2011-10-25
End date: 2011-10-25
Fentanyl-100
Indication: Pain
Start date: 2005-01-01
End date: 2011-10-27
Fentanyl-100
Indication: Procedural Pain
Start date: 2005-01-01
End date: 2011-10-27
Metoclopramide
Administration route: Oral
Indication: Uterine Contractions During Pregnancy
Morphine Hydrochloride
Indication: Uterine Contractions During Pregnancy
Start date: 2005-01-01
Ultiva
Indication: General Anaesthesia
Start date: 2011-10-25
End date: 2011-10-25
Possible Ultiva side effects in
Reported by a pharmacist from Japan on 2012-07-25
Patient:
Reactions: Anaphylactic Shock
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Diprivan
Indication: General Anaesthesia
Rocuronium Bromide
Ultiva
Possible Ultiva side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-23
Patient: female
Reactions: Maternal Drugs Affecting Foetus, Caesarean Section, Premature Baby, Foetal Exposure During Pregnancy, Heart Sounds Abnormal
Drug(s) suspected as cause:
Dopamine HCL
Indication: Maternal Exposure During Pregnancy
Isoflurane
Indication: Maternal Exposure During Pregnancy
Levothyroxine Sodium
Indication: Maternal Exposure During Pregnancy
Ultiva
Indication: Maternal Exposure During Pregnancy
Possible Ultiva side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-23
Patient: female
Reactions: Premature Baby, Foetal Exposure During Pregnancy, Heart Sounds Abnormal
Drug(s) suspected as cause:
Dopamine HCL
Indication: Maternal Exposure During Pregnancy
Isoflurane
Indication: Maternal Exposure During Pregnancy
Levothyroxine Sodium
Indication: Maternal Exposure During Pregnancy
Ultiva
Indication: Maternal Exposure During Pregnancy
Possible Ultiva side effects in 38 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-20
Patient: 38 year old female
Reactions: Convulsions Local, Delayed Recovery From Anaesthesia
Drug(s) suspected as cause:
Buprenorphine HCL
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-02
End date: 2012-07-02
Ultiva
Dosage: unknown dosage details
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Propofol
Possible Ultiva side effects in 16 year old male
Reported by a pharmacist from United States on 2012-07-12
Patient: 16 year old male, weighing 115.8 kg (254.8 pounds)
Reactions: Cardiac Arrest
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Diprivan
Dosage: once iv { 1 hour
Indication: Anaesthesia
Start date: 2012-07-02
End date: 2012-07-02
Ultiva
Dosage: once iv { 1 hour
Indication: Anaesthesia
Start date: 2012-07-02
End date: 2012-07-02
Possible Ultiva side effects in 62 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-12
Patient: 62 year old male
Reactions: Cardiac Arrest
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Bimatoprost and Timolol Maleate
Dosage: unk
Indication: Glaucoma
Start date: 2000-01-01
Diprivan
Dosage: 150 mg, unknown
Indication: Anaesthesia
Start date: 2011-06-06
Nimbex
Dosage: 12 mg, single (iv, syringe pump)
Indication: Anaesthesia
Start date: 2011-06-06
Sufentanil Citrate
Dosage: 15 units, unknown
Indication: Anaesthesia
Start date: 2011-06-06
Ultiva
Dosage: 1.5 mg/kg/min
Indication: Anaesthesia
Start date: 2011-06-06
Other drugs received by patient: Trusopt
Possible Ultiva side effects in
Reported by a physician from Japan on 2012-07-06
Patient: , weighing 2.3 kg (5.1 pounds)
Reactions: Premature Baby, Foetal Exposure During Pregnancy, Heart Sounds Abnormal
Drug(s) suspected as cause:
Dopamine HCL
Indication: Maternal Exposure Timing Unspecified
Isoflurane
Indication: Maternal Exposure Timing Unspecified
Levothyroxine Sodium
Indication: Maternal Exposure Timing Unspecified
Ultiva
Indication: Maternal Exposure Timing Unspecified
Possible Ultiva side effects in 17 year old male
Reported by a physician from Japan on 2012-07-02
Patient: 17 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Airway Peak Pressure Increased, Generalised Erythema, Mechanical Ventilation Complication, Rash
Drug(s) suspected as cause:
Atropine
Start date: 2011-06-20
End date: 2011-06-20
Cefazolin Sodium
Start date: 2011-06-20
End date: 2011-06-20
Diprivan
Dosage: 10mg/ml, 1200mg/hr
Indication: General Anaesthesia
Start date: 2011-06-20
Diprivan
Start date: 2011-06-20
End date: 2011-06-20
Fentanyl
Indication: Anaesthesia Procedure
Start date: 2011-06-20
End date: 2011-06-20
Fentanyl
Start date: 2011-06-20
End date: 2011-06-20
Flurbiprofen
Indication: Analgesic Therapy
Start date: 2011-06-20
End date: 2011-06-20
Isotonic Sodium Chloride Solution
Start date: 2011-06-20
End date: 2011-06-20
Mepivacaine HCL
Indication: Analgesic Therapy
Start date: 2011-06-20
End date: 2011-06-20
Mepivacaine HCL
Dosage: 20mg/ml
Physio 140
Start date: 2011-06-20
End date: 2011-06-20
Ropivacaine Hydrochloride
Dosage: 0.375%, 4 ml/hr continuously
Start date: 2011-06-20
End date: 2011-06-20
Ropivacaine Hydrochloride
Indication: Analgesic Therapy
Start date: 2011-06-20
End date: 2011-06-20
Salinhes
Start date: 2011-06-20
End date: 2011-06-20
Ultiva
Indication: Anaesthesia Procedure
Start date: 2011-06-20
End date: 2011-06-20
Ultiva
Dosage: 0.5mg/hr
Start date: 2011-06-20
End date: 2011-06-20
Xylocaine
Indication: Analgesic Therapy
Start date: 2011-06-20
End date: 2011-06-20
Other drugs received by patient: Relaxin; Polaramine; Neophyllin Injection; Hydrocortisone Sodium Succinate; Rocuronium Bromide
Possible Ultiva side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21
Patient: male, weighing 4.5 kg (9.9 pounds)
Reactions: Respiratory Rate Decreased, Incorrect Dose Administered, Accidental Overdose
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Propofol
Indication: General Anaesthesia
Ultiva
Dosage: dose unit:5.4
Indication: General Anaesthesia
Other drugs received by patient: Sodium Chloride
Possible Ultiva side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-18
Patient: 59 year old male
Reactions: Tachycardia, Hypotension, Bronchospasm
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Propofol
Dosage: iv
Indication: Induction of Anaesthesia
Start date: 2012-02-20
End date: 2012-02-20
Rocuronium Bromide
Dosage: iv
Indication: Induction of Anaesthesia
Start date: 2012-02-20
End date: 2012-02-20
Ultiva
Dosage: iv
Indication: Induction of Anaesthesia
Start date: 2012-02-20
End date: 2012-02-20
Possible Ultiva side effects in 48 year old female
Reported by a individual with unspecified qualification from France on 2012-06-14
Patient: 48 year old female
Reactions: Urticaria, Rash, Tryptase Increased
Drug(s) suspected as cause:
Propofol
Dosage: 1 df; once; iv
Indication: General Anaesthesia
Start date: 2012-02-08
End date: 2012-02-08
Rocuronium Bromide
Dosage: 1 df; once; iv
Indication: General Anaesthesia
Start date: 2012-02-08
End date: 2012-02-08
Ultiva
Dosage: 1 df; once; iv
Indication: General Anaesthesia
Start date: 2012-02-08
End date: 2012-02-08
Possible Ultiva side effects in 68 year old male
Reported by a physician from Japan on 2012-06-12
Patient: 68 year old male
Reactions: Pharyngeal Oedema, Respiratory Arrest
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Diprivan
Dosage: 100 mg; once; iv
Indication: Anaesthesia Procedure
Start date: 2011-11-24
End date: 2011-11-24
Rocuronium Bromide
Dosage: 50 mg; once; iv
Indication: Neuromuscular Blocking Therapy
Start date: 2011-11-24
End date: 2011-11-24
Ultiva
Dosage: 0.5 mcg/kg; iv
Indication: Analgesic Therapy
Start date: 2011-11-24
End date: 2011-11-24
Possible Ultiva side effects in 81 year old male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-07
Patient: 81 year old male
Reactions: Tongue Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Perindopril Erbumine
Dosage: oral
Administration route: Oral
Indication: Hypertension
Start date: 2012-04-03
End date: 2012-04-03
Propofol
Dosage: intravenous (not otherwise specified)
Indication: Induction of Anaesthesia
Start date: 2012-04-03
End date: 2012-04-03
Rocuronium Bromide
Dosage: intravenous (not otherwise specified)
Indication: Induction and Maintenance of Anaesthesia
Start date: 2012-04-03
End date: 2012-04-03
Ultiva
Dosage: intravenous (not otherwise specified)
Indication: Induction and Maintenance of Anaesthesia
Start date: 2012-04-03
End date: 2012-04-03
Other drugs received by patient: Perfalgan (Paracetamol) (Paracetamol)
Possible Ultiva side effects in 17 year old male
Reported by a physician from Japan on 2012-06-04
Patient: 17 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Airway Peak Pressure Increased, Generalised Erythema, Mechanical Ventilation Complication, Rash
Drug(s) suspected as cause:
Atropine
Start date: 2011-06-20
End date: 2011-06-20
Cefazolin Sodium
Start date: 2011-06-20
End date: 2011-06-20
Diprivan
Start date: 2011-06-20
End date: 2011-06-20
Diprivan
Dosage: 10mg/ml, 1200mg/hr
Indication: General Anaesthesia
Start date: 2011-06-20
Fentanyl
Indication: Anaesthesia Procedure
Start date: 2011-06-20
End date: 2011-06-20
Fentanyl
Start date: 2011-06-20
End date: 2011-06-20
Flurbiprofen
Indication: Analgesic Therapy
Start date: 2011-06-20
End date: 2011-06-20
Isotonic Sodium Chloride Solution
Start date: 2011-06-20
End date: 2011-06-20
Mepivacaine HCL
Indication: Analgesic Therapy
Start date: 2011-06-20
End date: 2011-06-20
Mepivacaine HCL
Dosage: 20mg/ml
Physio 140
Start date: 2011-06-20
End date: 2011-06-20
Ropivacaine Hydrochloride
Indication: Analgesic Therapy
Start date: 2011-06-20
End date: 2011-06-20
Ropivacaine Hydrochloride
Dosage: 0.375%, 4 ml/hr continuously
Start date: 2011-06-20
End date: 2011-06-20
Salinhes
Start date: 2011-06-20
End date: 2011-06-20
Ultiva
Dosage: 0.5mg/hr
Start date: 2011-06-20
End date: 2011-06-20
Ultiva
Indication: Anaesthesia Procedure
Start date: 2011-06-20
End date: 2011-06-20
Xylocaine
Indication: Analgesic Therapy
Start date: 2011-06-20
End date: 2011-06-20
Other drugs received by patient: Rocuronium Bromide; Hydrocortisone Sodium Succinate; Neophyllin Injection; Relaxin; Polaramine
Possible Ultiva side effects in 81 year old male
Reported by a physician from Italy on 2012-05-31
Patient: 81 year old male
Reactions: Tongue Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Perindopril Erbumine
Dosage: 5 mg; qd; po
Administration route: Oral
Indication: Hypertension
Start date: 2010-01-01
End date: 2012-04-03
Propofol
Dosage: 130 mcg; once; iv
Indication: Anaesthesia
Start date: 2012-04-03
End date: 2012-04-03
Rocuronium Bromide
Dosage: 40 mg; once; iv
Indication: Anaesthesia
Start date: 2012-04-03
End date: 2012-04-03
Ultiva
Dosage: 2 mg; once; iv
Indication: Anaesthesia
Start date: 2012-04-03
End date: 2012-04-03
Other drugs received by patient: Acetaminophen
Possible Ultiva side effects in 17 year old male
Reported by a physician from Japan on 2012-05-21
Patient: 17 year old male
Reactions: Airway Peak Pressure Increased, Generalised Erythema, Mechanical Ventilation Complication, Rash
Drug(s) suspected as cause:
Carbocain
Dosage: 20mg/ml
Indication: Pain Management
Cefazolin Sodium
Start date: 2011-06-20
End date: 2011-06-20
Fentanyl-100
Indication: Anaesthesia Procedure
Start date: 2011-06-20
End date: 2011-06-20
Flurbiprofen
Dosage: 50 mg
Indication: Pain Management
Start date: 2011-06-20
End date: 2011-06-20
Propofol
Dosage: 10mg/ml, total dose of was 2161 mg (bolus administration 200mg, continuous administration 1061mg)
Start date: 2011-06-20
End date: 2011-06-20
Propofol
Dosage: 10mg/ml, 1200mg/hr
Indication: General Anaesthesia
Start date: 2011-06-20
Propofol
Dosage: 10mg/ml, 360mg/hr
Start date: 2011-06-20
Propofol
Dosage: 10mg/ml, with target of blood concentration of 300mg/hr (after 14:15) 280mg/hr (after 15:15)
Start date: 2011-06-20
Propofol
Dosage: 10mg/ml, with target of blood concentration of 350mg/hr (after 15:35) and 250 mg/hr (after 16:45)
Start date: 2011-06-20
End date: 2011-06-20
Ropivacaine Hydrochloride
Dosage: 0.375%, 4 ml/hr continuously
Indication: Pain Management
Start date: 2011-06-20
End date: 2011-06-20
Ultiva
Dosage: 0.2mg/hr
Start date: 2011-06-20
Ultiva
Dosage: 0.5mg/hr
Indication: Anaesthesia Procedure
Start date: 2011-06-20
End date: 2011-06-20
Other drugs received by patient: Xylocaine; NI; Polaramine; Hydrocortisone Sodium Succinate; Salinhes; Rocuronium Bromide; Neophyllin Injection; Atropine; Physio 140; Relaxin
|
